Adial Pharmaceuticals, Inc. (ADIL) vs BioVie Inc. (BIVI)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and BioVie Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.20HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
BIVI
BioVie Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT
Total return — ADIL vs BIVI
growth of $100 · dividends reinvested · last 8yADIL -99.8% (-54.9%/yr)BIVI -99.9% (-58.3%/yr)ADIL compounded faster over this window
ADIL BIVI
ADIL vs BIVI: by the numbers
- •BIVI is the larger company ($11M vs $11M market cap).
Metrics side by side
Valuation
| Metric | ADIL | BIVI |
|---|---|---|
| P/B ratio | N/A | 1.08 |
Profitability
| Metric | ADIL | BIVI |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -37052.06% | -214.92% |
| ROIC | -240.64% | -216.67% |
Growth (annualized)
| Metric | ADIL | BIVI |
|---|---|---|
| Total return CAGR (5Y) | -71.86% | -70.37% |
Frequently asked
- How have ADIL and BIVI total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and BIVI delivered -70.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.